Molecular advances of brain tumors in radiation oncology.
about
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaConnexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.STAT6 expression in glioblastoma promotes invasive growthExpression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factorMicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.RasGRP3 regulates the migration of glioma cells via interaction with Arp3miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells.A functional screen identifies miRs that induce radioresistance in glioblastomas.Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma.Compound 331 selectively induces glioma cell death by upregulating miR-494 and downregulating CDC20.RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK.Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.Pediatric glioblastoma multiforme: A single-institution experience.Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma.Proton-beam therapy for tumors of the CNS.Towards tailored therapy of glioblastoma multiforme.Brain tumors in children--current therapies and newer directions.Controversies and challenges regarding the impact of radiation therapy on survival.MiR-429 suppresses glioblastoma multiforme by targeting SOX2.MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2.Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells.Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2.Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance.Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma.14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death.E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.Tunneling nanotubes between rat primary astrocytes and C6 glioma cells alter proliferation potential of glioma cellsFET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.Identification of a gene signature associated with radiotherapy and prognosis in gliomas.Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124.The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
P2860
Q24632791-74BB5CA8-ED87-48E1-8A46-D42B3495C4BFQ27322751-130D3BB0-BA82-47CB-BE6D-8F5C0CF8AB41Q30431789-03CD87F1-7460-4B0B-8575-75FC8B0865B8Q34395707-1EA82B09-C6A4-4662-9A89-70328EB39CC5Q34579942-852885E1-54F0-4BAF-A651-54A4671B019BQ35038680-98D7EB3D-E76E-4572-81A5-D6B507466353Q35176456-73827D19-3D44-4087-88B4-70EE24174724Q35284695-6179794B-E28B-446F-8093-5D489AF46713Q35285532-23605485-0105-4B3C-97BF-F76642B67331Q35802967-3E3D7790-E0C5-4811-AD21-88610EB0BAFCQ35830062-7E88169D-4991-4A61-B9BF-AAE3BDCB7CC3Q36260652-A6C22FEC-67C1-4BB9-B3F5-E1E86288B760Q36307209-501F48E2-2FCE-4D3D-9547-C6F3BC713D41Q36356040-CAABA434-B8F5-4322-AA71-4A99DB29B1B6Q36470140-F06B7260-C9E5-46D2-BEA0-2F533A78B195Q37016591-A121260A-9815-4A89-B487-62E6F9AA732DQ37320946-5641EC42-48F3-438B-97B3-9819874CD0A9Q37688085-65E4881C-6884-4BC0-852C-36A097B4CBCBQ37908815-28934F7A-16D7-438F-A61E-9D14A443D5C9Q37980395-63B07A80-C239-4F73-A049-B48AFBAABEBBQ38035079-627B0E8A-B95E-434F-845F-94855BCA9580Q38696293-B650B194-8A76-432A-9FF6-3066A1FE79ABQ38696999-B983C924-C969-4AD0-A3B8-4989718675D0Q38728168-15C80E23-B2CB-4958-956C-70B231924422Q38752222-8C9E1AE4-0AC8-4829-B143-50439F902904Q38836365-287F5D61-989A-4D6D-AF7D-61D9263F9030Q38867874-7E6A606F-D144-44F9-85A2-D64867B24EE4Q38922566-67952928-54E9-4944-871D-DD29B7EF6AA4Q39015881-BC4ED303-0025-47CC-B9D9-F103BF1A0AB3Q39066576-518FF582-D706-4B34-8DEA-D8FCFE2D0BBDQ39352683-7A7E7BC1-A89E-4512-9FAB-230333DBCC6EQ41013527-C93D0243-32F2-4DA6-8FD8-A4D0330E2217Q41921083-3BA40313-BD9B-4CD1-9FC6-E4A085A5F479Q42123071-64C882A6-542F-492C-8DC9-72E006D2EFF7Q45339162-0EC63998-0777-4EBC-BB29-5F5837C85A39Q45673083-7A22000B-B6FF-48F4-B2BC-065623D857EAQ47640908-051B3A5E-D929-4FFD-AC6A-FE9BB91A6FC0
P2860
Molecular advances of brain tumors in radiation oncology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular advances of brain tumors in radiation oncology.
@en
Molecular advances of brain tumors in radiation oncology.
@nl
type
label
Molecular advances of brain tumors in radiation oncology.
@en
Molecular advances of brain tumors in radiation oncology.
@nl
prefLabel
Molecular advances of brain tumors in radiation oncology.
@en
Molecular advances of brain tumors in radiation oncology.
@nl
P2093
P1476
Molecular advances of brain tumors in radiation oncology.
@en
P2093
Areej El-Jawahri
Arnab Chakravarti
Disha Patel
Michael Siedow
Shin-ei Noda
Tim Lautenschlaeger
P304
P356
10.1016/J.SEMRADONC.2009.02.005
P577
2009-07-01T00:00:00Z